uniQure is a Netherlands-based biotechnology company developing gene therapies for serious genetic diseases such as hemophilia and Huntington's disease.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Paul Tudor Jones / Tudor | 61 | Added +19% | 1,281,663 | $30,964,978 | 0.0% |
| Steve Cohen / Point72 | 75 | Trimmed -45% | 330,665 | $7,988,866 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.